SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-10-003307
Filing Date
2010-09-09
Accepted
2010-09-09 16:29:14
Documents
6
Period of Report
2010-07-31

Document Format Files

Seq Description Document Type Size
1 PEREGRINE PHARMACEUTICALS, INC. peregrine_10q.htm 10-Q 844158
2 LICENSE AGREEMENT peregrine_10q-ex1026.htm EX-10.26 298140
3 ASSIGNMENT AGREEMENT peregrine_10q-ex1027.htm EX-10.27 273450
4 CERTIFICATION peregrine_ex3101.htm EX-31.1 12276
5 CERTIFICATION peregrine_ex3102.htm EX-31.2 12302
6 CERTIFICATION peregrine_ex3201.htm EX-32 12912
  Complete submission text file 0001019687-10-003307.txt   1455020
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-32839 | Film No.: 101064648
SIC: 2835 In Vitro & In Vivo Diagnostic Substances